| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0018 | 1 |